Health CanadaGeneral Alert
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
Published: December 20, 2018Recall ID: 58819Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
Additional Source Details
| Field | Value |
|---|---|
| N I D | 58819 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/xarelto-rivaroxaban-increase-all-cause-mortality-thromboembolic-and-bleeding-events |
| Issue | Product safety |
| Title | XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2018-12-20 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement Check if your household is affected: https://therecallfile.com/recalls/xarelto-rivaroxaban-increase-in-all-cause-mortality-thromboembolic-and/CANADA-58819
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordXARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement